Medicare recipients who take expensive prescriptions will get a break this year with a $2,000 cap on drug costs. The cap will reduce out-of-pocket spending for potentially millions of older Americans in Medicare Part D, which covers pharmacy or mail-order ...

The median wait time between referral and appointment was 34 days, and 18 percent of patients waited more than 90 days, the study found.

The Biden administration said Medicare will negotiate discounts with drug companies on 15 drugs prescribed to treat cancer, diabetes and asthma.

Ozempic and Wegovy, the blockbuster but costly GLP-1 drugs often used for weight loss, are among the 15 medications that will be subject to the next round of Medicare price negotiations, the Biden administration announced Friday.

Medicare premiums and deductibles have increased for all retirees. There's now a $2,000 cap on annual out-of-pocket prescription drug costs. Some Medicare services, like telehealth, have gotten more restrictive in 2025.

The U.S. government on Friday announced a list of 15 prescription medicines targeted for Medicare price negotiations for 2027, which includes Novo Nordisk's blockbuster weight-loss drug Wegovy.Here's

The hugely popular medications Ozempic and Wegovy​, used for diabetes and weight loss, will be included in the next round of talks to negotiate lower Medicare drug prices.

The Biden administration says popular weight loss drugs like Ozempic and Wegovy have been added to Medicare’s list of medications that will be negotiated directly between the government and drug manufacturers.

Although Medicare enrollees typically don't pay a premium for Part A, which covers hospital care, there's a cost for being admitted to the hospital. In 2025, you'll face a $1,676 inpatient deductible, up from $1,632 in 2024.

If you missed Medicare's open enrollment period, which runs from October 15 to December 7 each year, you may be wondering if there's still a way to enroll or adjust your coverage w

CEO Andrew Witty promised that UnitedHealthcare would work to speed up turnaround times for approval of some procedures and services in Medicare Advantage plans.